Download presentation
Presentation is loading. Please wait.
Published byLilian Osborne Modified over 9 years ago
1
SENIOR ORAL MEDICINE Chapter 1: Physical Evaluation & Risk Assessment Susan Settle, D.D.S. August 26, 2010
2
Interrelationships Of Medicine And Dentistry Physical Evaluation & Risk Assessment Practice Goals Deliver The Best Care Possible For The Patient Be Aware What Impact The Systemic Status And Medications May Have On Delivery Of Treatment To Feel Comfortable Treating A Variety Of Patients
3
Value Of The Health History Questionnaire & Medical History It Is The Cornerstone Of Patient Evaluation & Risk Assessment Identifies Systemic Disease Identifies Medications Establishes Rapport Medicolegal Protection For The Practitioner
4
Risk Assessment Involves Identification Of: vNature, Severity, & Stability Of The Patient’s Medical Condition vFunctional Capacity Of The Patient vEmotional State Of The Patient vType & Magnitude Of The Dental Procedure
5
American Society Of Anesthesiologists Classification Of Patients Based On Medical Assessment Of Patient
6
ASA Classification Groups ASA I Normal, Healthy Patient ASA II Mild Disease Does Not Interfere With Daily Activities May Need Some Alteration Of Dental Treatment Examples: Mild HTN Or COPD,Type II Diabetes, Allergy, Well-Controlled Epilepsy Or Asthma
7
ASA Classification Groups ASA III Moderate To Severe Systemic Disease May Alter Daily Activities Generally Requires Alteration Of Dental Treatment Medications Type I Diabetes, Moderate To Severe HTN, Angina, CHF, AIDS, COPD, Hemophilia, MI In Last 6 Months
8
ASA Classification Groups ASA IV Severe Systemic Disease Life-Threatening Conditions Requires Alteration Of Dental Management ESRD, Liver Failure, Advanced AIDS
9
ASA Physical Status P1A normal healthy patient P2A patient with mild systemic disease P3A patient with severe systemic disease P4A patient with severe systemic disease that is a constant threat to life P5A moribund patient who is not expected to survive without the operation P6A declared brain-dead patient whose organs are being removed for donor purposes
10
Patients Requiring Further Evaluation By The Anesthesiologist For General Surgery Morbid Obesity (BMI>38) MI Within 6 Months Angioplasty Within 3 Months History Of Heart Transplant History Of Unstable Angina
11
Patients Requiring Further Evaluation By The Anesthesiologist For General Surgery History Of Carotid Surgery Within 6 Months History Of Steroid-Dependent Asthma Or COPD Particularly With URI In Last 4 Weeks (Upper Respiratory Infection) Seizure Within 3 Months While Taking Anticonvulsants
12
Patients Requiring Further Evaluation By The Anesthesiologist For General Surgery History Of Allergy To Local Anesthetics History Of Dialysis Or Renal Transplant History Of CVA/TIA Within 6 Months (Cerebrovascular Accident/Transient Ischemic Attack) Systolic BP>200 And/Or Diastolic BP>100 History Of Cirrhosis (Need Recent CBC, INR, LFT)
13
Risk Assessment ABCs Of Risk Assessment Are More Helpful Than The ASA Physical Classification System ASA System Does Not Provide Information About Modification Of Treatment
14
Risk Assessment A: Antibiotics Anesthesia Anxiety Allergy B: Bleeding C: Chair Position D: Drugs Devices E: Equipment Emergencies
15
Medical History Overview Cardiovascular Diseases Heart Failure (CHF) A Clinical Syndrome Complex No Routine Treatment If Not Controlled Consider Chair Position Cardiac Glycosides (Digoxin, Lanoxin) + Vasoconstrictors Arrhythmias (Avoid Vasoconstrictors If Possible)
16
Medical History Overview Cardiovascular Diseases (Cont.) Myocardial Infarction No Routine Treatment If In Last 1-6 Months (Refer To Your Text!) Increased Risk Of Reinfarction, CHF & Arrhythmias
17
Medical History Overview Angina Pectoris Stable Unstable: Chest Pain At Rest Increased Incidence Of Arrhythmias, MI’s, Sudden Death Elective Treatment Contraindicated Cardiovascular Diseases (Cont.)
18
Medical History Overview Hypertension Non-Selective Beta-Blockers (Propranolol, Inderal) +Vasoconstrictors Possible Hypertensive Crisis Cardiovascular Diseases (Cont.)
19
Medical History Overview Murmur Functional Organic Regurgitation Associated With MVP Diagnosed By Echocardiogram No Recommendation For Endocarditis Prophylaxis From AHA Cardiovascular Diseases (Cont.)
20
Medical History Overview Rheumatic Heart Disease From Rheumatic Fever Following A Beta-Hemolytic Streptococcal Infection Valve Damage? No Recommendation For Endocarditis Prophylaxis Cardiovascular Diseases (Cont.)
21
Medical History Overview Congenital Heart Disease Prosthetic Heart Valves Arrhythmias: Frequently Related To Heart Failure Or Ischemic Disease Cardiovascular Diseases (Cont.)
22
Medical History Overview Cardiac Surgery CABG (Coronary Artery Bypass Graft) Transplant: Immunosuppression Considerations Cardiovascular Diseases (Cont.)
23
Medical History Overview Stroke Or CVA: Anticoagulation Possibilities Aneurysm: If Repaired, No Prophylaxis Required After 6 Months Cardiovascular Diseases (Cont.)
24
Medical History Overview Hematologic Disorders Transfusion: Why Was It Done? Risks Anemia Leukemia “Bleeds Longer Than Normal” Genetic (Hemophilias) Acquired (Pharmacotherapy)
25
Medical History Overview Neural/Sensory Disorders Headache, Dizziness, Syncope Glaucoma: Avoid Anticholinergic Drugs If Patient Has Closed-Angle Glaucoma (Banthine, Pro-Banthine) Given To “Dry Up” Saliva Epilepsy, Seizures, Convulsions Psychiatric Treatment
26
Medical History Overview GI Diseases Peptic Ulcer Disease (PUD) Inflammatory Bowel Disease (Crohn’s, Ulcerative Colitis - IBD) Irritable Bowel Syndrome (IBS) Hepatitis, Cirrhosis
27
Medical History Overview Respiratory Diseases Allergic History COPD-Chronic Obstructive Pulmonary Disease (Emphysema, Chronic Bronchitis) Asthma Tuberculosis Sleep Apnea/Snoring
28
Medical History Overview Musculoskeletal, Mucocutaneous, Dermal Prosthetic Joints Arthritis (Osteo & Rheumatoid)
29
Medical History Overview Autoimmune Disorders Rheumatoid Arthritis SLE (Systemic Lupus Erythematosus) Sjögren’s Syndrome
30
Medical History Overview Scleroderma RAS (Recurrent Aphthous Stomatitis) Or “Major” Aphthous Autoimmune Disorders
31
Medical History Overview Endocrine Diseases Diabetes Thyroid (Hypo, Hyper) Urinary Tract Kidney Disease Bladder Disease
32
Medical History Overview Sexually-Transmitted Diseases Gonorrhea Syphilis HIV Positive AIDS
33
Medical History Overview Social History Tobacco Alcohol Recreational Drugs
34
Medical History Overview Cancer History Or Treatment Chemotherapy Radiation Therapy Surgery
35
Medical History Overview Operations/Hospitalizations & Sequelae Anesthesia Complications
36
Medical History Overview Medications Use Appropriate References When Looking Up Something Steroids, Anticoagulants, Immunosuppressives Allergies, Adverse Reactions Stress Importance Of OTC (Over The Counter) Drugs
38
Medical History Overview Dental History Vital Signs: Initial Exam, Recalls, Whenever Indicated Pulse Rate & Rhythm (60-100 bpm) BP: S <120; D <80 Respiration (12-16 bpm)
39
Medical History Overview General Physical Assessment Gait, Speech, Skin, Nails, Eyes, Nose, Ears, Neck
40
Medical History Overview Laboratory Tests (Indicated?) Hematocrit, Hemoglobin Platelet Count, PT (INR) Fasting Blood Glucose Biopsy Culture & Sensitivity Who Orders The Tests?
41
Communication With Physician HIPAA Forms Must Be Filled Out By Patient At Physician’s Office HIPAA Forms Must Be Filled Out By Patient At Dentist’s Office
42
Communication With Physician Phone & “Sidewalk” Consults Should Be Documented In Progress Notes Formal Documentation Preferred
43
And Now For Some Relatively New Stuff: 2007 AHA Guidelines for Endocarditis Prophylaxis History Of Bisphosphonate Use 2009 American Association of Orthopaedic Surgeons Information Statement Regarding Prosthetic Joint Prophylaxis
44
Risk Is Always Increased When You Treat A Medically Compromised Patient Your Goal Is To Reduce The Risk As Much As Possible
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.